Instadose Pharma (Instadose Pharma) YoY EBITDA Growth : 95.00% (As of Feb. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Instadose Pharma YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Instadose Pharma's YoY EBITDA Growth for the quarter that ended in Feb. 2022 was 95.00%.

Instadose Pharma's EBITDA per Share for the three months ended in Feb. 2022 was $-0.00.

Instadose Pharma YoY EBITDA Growth Historical Data

The historical data trend for Instadose Pharma's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Instadose Pharma YoY EBITDA Growth Chart

Instadose Pharma Annual Data

Trend

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

YoY EBITDA Growth

Get a 7-Day Free Trial

Instadose Pharma Quarterly Data
	May17	Aug17	Nov17	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22
YoY EBITDA Growth	Get a 7-Day Free Trial															-	-	-	-	95.00

Instadose Pharma YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Instadose Pharma's YoY EBITDA Growth for the fiscal year that ended in Nov. 2021 is calculated as:

	YoY EBITDA Growth (A: Nov. 2021 )
=	(EBITDA per Share (A: Nov. 2021 )	-	EBITDA per Share (A: Nov. 2020 ))	/	\| EBITDA per Share (A: Nov. 2020 ) \|
=	(-0.006	-	-0)	/	\| -0 \|
=	N/A %

Instadose Pharma's YoY EBITDA Growth for the quarter that ended in Feb. 2022 is calculated as:

	YoY EBITDA Growth (Q: Feb. 2022 )
=	(EBITDA per Share (Q: Feb. 2022 )	-	EBITDA per Share (Q: Feb. 2021 ))	/	\| EBITDA per Share (Q: Feb. 2021 )) \|
=	(-0.001	-	-0.02)	/	\| -0.02 \|
=	95.00 %

Instadose Pharma YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Instadose Pharma's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Instadose Pharma (Instadose Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Instadose Pharma Corp (OTCPK:INSD) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

5500 North Service Road, Suite 301, Burlington, ON, CAN, L7L 6W6

Website

https://www.instadosepharma.com

Instadose Pharma Corp, formerly Mikrocoze Inc is seeking to create a global distribution platform for medicinal cannabis and cannabinoid oil. The company endeavors to utilize the Global Distribution Platform to open the commercial gateway to a new wholesale marketplace along with providing pharmaceutical industry companies with large, sustainable, consistent, diverse, and low?cost supplies of high?quality medicinal cannabis and cannabinoid oil for use in bulk as an active pharmaceutical ingredient.